biotech · Solid Tumor Malignancies · FENC
FENNEC PHARMACEUTICALS
FENNEC PHARMACEUTICALS INC.
FENNEC PHARMACEUTICALS patent portfolio — 8 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Research Triangle Park, USA
- Founded
- 1996
- Employees
- 54
- Programs
- 1
- Drugs
- 1
- Patents
- 8
FENNEC PHARMACEUTICALS patents
8 pharmaceutical patents indexed for FENNEC PHARMACEUTICALS. 0 expire within 24 months.
FENNEC PHARMACEUTICALS has 8 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12311026
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11998604
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11992530
Therapeutic uses for sodium thiosulfate and formulations
granted -
US 11964018
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11617793
Anhydrous sodium thiosulfate and formulations thereof
granted -
US 11510984
Anhydrous sodium thiosulfate and formulations thereof
granted -
US 11291728
Anhydrous sodium thiosulfate and formulations thereof
granted -
US 10792363
Anhydrous sodium thiosulfate and formulations thereof
granted
Frequently asked questions
How many patents does FENNEC PHARMACEUTICALS have?
8 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do FENNEC PHARMACEUTICALS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.